Distinct SF3B1 Allele HEAT Repeat Location Is Associated with Co-Occurring Mutation Patterns in MDS

被引:0
|
作者
Dukenik, David Bared [1 ,2 ]
Soong, Deborah [2 ]
Scarpa, Frank [3 ]
Anderson, Julia [4 ]
Li, Hua [2 ]
Udayakuma, Viji [2 ]
Watts, Justin M. [2 ]
Madanat, Yazan F. [4 ]
Sekeres, Mikkael A. [5 ]
Chandhok, Namrata Sonia [6 ]
Taylor, Justin [2 ]
机构
[1] Nova Southeastern Univ, Dr Kiran C Patel Sch Allopath Med, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[3] Neogen Labs Inc, Ft Myers, FL USA
[4] UT SouthWestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
[5] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[6] Univ Miami, Miller Sch Med, Div Hematol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
关键词
D O I
10.1182/blood-2023-181191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Myeloid Neoplasms with Ring Sideroblasts without SF3B1 Mutation
    Bhaysar, S.
    Bailey, N. G.
    Liu, Y.
    Coyne, W. E.
    Aggarwal, N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 925 - 926
  • [32] Therapeutic Applications of a Unique Calcium Channel Blocker to Target SF3B1 MDS
    Kongkiatkamon, Sunisa
    Tiwari, Anand
    Adema, Vera
    Kerr, Cassandra M.
    Przychodzen, Bartlomiej
    Awada, Hassan
    Durrani, Jibran
    Parker, Yvonne
    Adams, Drew
    Fedorov, Yuriy
    Carraway, Hetty E.
    Yang, Chao-Yie
    Sekeres, Mikkael A.
    Lindner, Daniel J.
    Phillips, James G.
    Maciejewski, Jaroslaw P.
    Visconte, Valeria
    BLOOD, 2019, 134
  • [33] Uveal Melanomas with SF3B1 Mutations A Distinct Subclass Associated with Late-Onset Metastases
    Yavuzyigitoglu, Serdar
    Koopmans, Anna E.
    Verdijk, Robert M.
    Vaarwater, Jolanda
    Eussen, Bert
    van Bodegom, Alice
    Paridaens, Dion
    Kilic, Emine
    de Klein, Annelies
    OPHTHALMOLOGY, 2016, 123 (05) : 1118 - 1128
  • [34] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
    Song, Jinming
    Moscinski, Lynn
    Zhang, Hailing
    Zhang, Xiaohui
    Hussaini, Mohammad
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (01) : 91 - 98
  • [35] MUTATIONS OF SF3B1 GENE AND ITS SIGNIFICANCE ON PATIENTS WITH MYELODYSPASTIC SYNDROMES (MDS)
    Zemanova, Z.
    Aghova, T.
    Lhotska, H.
    Svobodova, K.
    Hodanova, L.
    Lizcova, L.
    Pavlistova, L.
    Luksikova, K.
    Sotakova, S.
    Minarik, L.
    Stopka, T.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2023, 128
  • [36] SF3B1 Mutation is Associated with Improved Long-term Survival in Metastatic Uveal Melanoma
    Ahmad, S.
    Ashwat, E.
    Wise, E. S.
    Tobin, J.
    Kammula, U. S.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S143 - S143
  • [37] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
    Song, Jinming
    Hussaini, Mohammad
    Talha, Rashid
    Zhang, Hailing
    Zhang, Ling
    Shao, Haipeng
    Zhang, Xiaohui
    Moscinski, Lynn
    LABORATORY INVESTIGATION, 2017, 97 : 379A - 379A
  • [38] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
    Song, Jimning
    Hussaini, Mohammad
    Talha, Rashid
    Zhang, Hailing
    Zhang, Ling
    Shao, Haipeng
    Zhang, Xiaohui
    Moscinski, Lynn
    MODERN PATHOLOGY, 2017, 30 : 379A - 379A
  • [39] The Significance of Variant Allele Frequency in SF3B1 Mutated Myelodysplastic Neoplasms/Syndromes
    Lachowiez, Curtis A.
    Asimomitis, Georgios
    Bernard, Elsa
    Tang, Ivory
    Creignou, Maria
    Germing, Ulrich
    Gattermann, Norbert
    Malcovati, Luca
    Cazzola, Mario
    Lindberg, Eva Hellstrom
    Papaemmanuil, Elli
    Loghavi, Sanam
    BLOOD, 2023, 142
  • [40] SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase
    Huber, Sandra
    Haferlach, Torsten
    Meggendorfer, Manja
    Hutter, Stephan
    Hoermann, Gregor
    Baer, Constance
    Kern, Wolfgang
    Haferlach, Claudia
    LEUKEMIA, 2022, 36 (12) : 2927 - 2930